| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |